West Pharma (WST) Posts Mixed Q4 Results; Guides FY11
West Pharmaceutical Services, Inc. (NYSE: WST) reported Q4 EPS of $0.42, $0.04 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
